Thomas Woiwode - 01 Jul 2021 Form 4/A - Amendment Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Director
Signature
/s/ Pierre Lorenzo(Attorney-in-Fact)
Issuer symbol
TPST
Transactions as of
01 Jul 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
20 Sep 2021, 20:13:06 UTC
Date Of Original Report
06 Jul 2021
Previous filing
29 Jun 2021
Next filing
27 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Stock Option (Right to Buy) Award $0 +6,635 $0.000000 6,635 01 Jul 2021 Common Stock 6,635 $11.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests over three (3) years, with one-third (1/3) of the award vesting on the first anniversary of the grant date and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.

Remarks:

The amended Form 4 is being filed to correct the vesting schedule of the option grant and to correct the price of the derivative security.